HIGHLIGHTS
- who: Dae Kyu Kim from the Review Board of Gangdong Hee University HospitalEmory University, United States have published the Article: Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response After Heterologous Immunizations With ChAdOx1/BNT162b2 in End-Stage Renal Disease Patients on Hemodialysis, in the Journal: (JOURNAL) of July/22,/2021
- what: This study investigated the humoral response following a heterologous vaccination schedule of ChAdOx1/BNT162b2 in ESRD patients receiving maintenance hemodialysis (HD). The study showed 100% of seroconversion in ESRD patients after 2 shots of heterologous vaccines, which is better efficacy than homologous vaccines. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.